Synopsis
Synopsis
0
EU WC
0
KDMF
0
VMF
0
Australia
0
US Patents
0
US Exclusivities
0
Health Canada Patents
Annual Reports
NA
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Molecular Weight | 75.53 g/mol |
---|---|
Molecular Formula | CaCl+ |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 1 |
Rotatable Bond Count | 0 |
Exact Mass | 74.9314435 g/mol |
Monoisotopic Mass | 74.9314435 g/mol |
Topological Polar Surface Area | 0 Ų |
Heavy Atom Count | 2 |
Formal Charge | 1 |
Complexity | 0 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
72
PharmaCompass offers a list of Calcium Chloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Calcium Chloride manufacturer or Calcium Chloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Calcium Chloride manufacturer or Calcium Chloride supplier.
PharmaCompass also assists you with knowing the Calcium Chloride API Price utilized in the formulation of products. Calcium Chloride API Price is not always fixed or binding as the Calcium Chloride Price is obtained through a variety of data sources. The Calcium Chloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A PLEGISOL IN PLASTIC CONTAINER manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of PLEGISOL IN PLASTIC CONTAINER, including repackagers and relabelers. The FDA regulates PLEGISOL IN PLASTIC CONTAINER manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. PLEGISOL IN PLASTIC CONTAINER API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of PLEGISOL IN PLASTIC CONTAINER manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A PLEGISOL IN PLASTIC CONTAINER supplier is an individual or a company that provides PLEGISOL IN PLASTIC CONTAINER active pharmaceutical ingredient (API) or PLEGISOL IN PLASTIC CONTAINER finished formulations upon request. The PLEGISOL IN PLASTIC CONTAINER suppliers may include PLEGISOL IN PLASTIC CONTAINER API manufacturers, exporters, distributors and traders.
click here to find a list of PLEGISOL IN PLASTIC CONTAINER suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A PLEGISOL IN PLASTIC CONTAINER DMF (Drug Master File) is a document detailing the whole manufacturing process of PLEGISOL IN PLASTIC CONTAINER active pharmaceutical ingredient (API) in detail. Different forms of PLEGISOL IN PLASTIC CONTAINER DMFs exist exist since differing nations have different regulations, such as PLEGISOL IN PLASTIC CONTAINER USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A PLEGISOL IN PLASTIC CONTAINER DMF submitted to regulatory agencies in the US is known as a USDMF. PLEGISOL IN PLASTIC CONTAINER USDMF includes data on PLEGISOL IN PLASTIC CONTAINER's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The PLEGISOL IN PLASTIC CONTAINER USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of PLEGISOL IN PLASTIC CONTAINER suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The PLEGISOL IN PLASTIC CONTAINER Drug Master File in Japan (PLEGISOL IN PLASTIC CONTAINER JDMF) empowers PLEGISOL IN PLASTIC CONTAINER API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the PLEGISOL IN PLASTIC CONTAINER JDMF during the approval evaluation for pharmaceutical products. At the time of PLEGISOL IN PLASTIC CONTAINER JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of PLEGISOL IN PLASTIC CONTAINER suppliers with JDMF on PharmaCompass.
A PLEGISOL IN PLASTIC CONTAINER CEP of the European Pharmacopoeia monograph is often referred to as a PLEGISOL IN PLASTIC CONTAINER Certificate of Suitability (COS). The purpose of a PLEGISOL IN PLASTIC CONTAINER CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of PLEGISOL IN PLASTIC CONTAINER EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of PLEGISOL IN PLASTIC CONTAINER to their clients by showing that a PLEGISOL IN PLASTIC CONTAINER CEP has been issued for it. The manufacturer submits a PLEGISOL IN PLASTIC CONTAINER CEP (COS) as part of the market authorization procedure, and it takes on the role of a PLEGISOL IN PLASTIC CONTAINER CEP holder for the record. Additionally, the data presented in the PLEGISOL IN PLASTIC CONTAINER CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the PLEGISOL IN PLASTIC CONTAINER DMF.
A PLEGISOL IN PLASTIC CONTAINER CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. PLEGISOL IN PLASTIC CONTAINER CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of PLEGISOL IN PLASTIC CONTAINER suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing PLEGISOL IN PLASTIC CONTAINER as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for PLEGISOL IN PLASTIC CONTAINER API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture PLEGISOL IN PLASTIC CONTAINER as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain PLEGISOL IN PLASTIC CONTAINER and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a PLEGISOL IN PLASTIC CONTAINER NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of PLEGISOL IN PLASTIC CONTAINER suppliers with NDC on PharmaCompass.
PLEGISOL IN PLASTIC CONTAINER Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of PLEGISOL IN PLASTIC CONTAINER GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right PLEGISOL IN PLASTIC CONTAINER GMP manufacturer or PLEGISOL IN PLASTIC CONTAINER GMP API supplier for your needs.
A PLEGISOL IN PLASTIC CONTAINER CoA (Certificate of Analysis) is a formal document that attests to PLEGISOL IN PLASTIC CONTAINER's compliance with PLEGISOL IN PLASTIC CONTAINER specifications and serves as a tool for batch-level quality control.
PLEGISOL IN PLASTIC CONTAINER CoA mostly includes findings from lab analyses of a specific batch. For each PLEGISOL IN PLASTIC CONTAINER CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
PLEGISOL IN PLASTIC CONTAINER may be tested according to a variety of international standards, such as European Pharmacopoeia (PLEGISOL IN PLASTIC CONTAINER EP), PLEGISOL IN PLASTIC CONTAINER JP (Japanese Pharmacopeia) and the US Pharmacopoeia (PLEGISOL IN PLASTIC CONTAINER USP).